BKD vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

BKD

40.8
AI Score
VS
BKD Wins

MD

37.5
AI Score

Investment Advisor Scores

BKD

41score
Recommendation
HOLD

MD

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BKD MD Winner
Forward P/E 45.6621 8.2102 MD
PEG Ratio 0.2804 0.2433 MD
Revenue Growth -8.9% 1.7% MD
Earnings Growth 0.0% -29.8% BKD
Tradestie Score 40.8/100 37.5/100 BKD
Profit Margin -4.7% 7.7% MD
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY BKD

Relative Price Performance (Last 90 Days)

BKD 1M: -8.4% · 3M: -27.7% MD 1M: +17.5% · 3M: +19.3%

Current Technical Phase

BKD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.9%), weak momentum, RSI 39

RSI (14): 38.9 · Price: $9.38

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 68

RSI (14): 68.5 · Price: $31.62

Fundamentals Snapshot

Metric BKD MD
Market Cap — —
Forward P/E 68.8 12.8
Trailing P/E — 17.2
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS -0.16 1.83
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BKD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.